Committed to unwavering research, integral to our mission, our fully equipped in-house R&D centre and pilot plant, supported by expert microbiology and biotechnology professionals, drive continuous innovation. We focus on enhancing existing product lines through the identification of new strains, host response characterization, and advancing understanding of probiotic mechanisms. Our efforts extend to improving formulation, dosing, and delivery technologies, as well as optimizing existing processes.
As a testament to our dedication, we continue to invest in state-of-the-art biotech facilities within our pilot plant. This strategic decision positions us at the forefront of the industry, allowing us to explore diverse probiotics and biotech molecules. The knowledge gained from our R&D initiatives not only furthers our product lines but also contributes significantly to the broader scientific community.  Aligning with customer needs, we develop tailored products, ranging from nutraceuticals to biotherapeutics and peptides, ensuring a seamless transition from research and pilot scale production to commercialization. This dedication defines our commitment to advancing biotech solutions.